CPSA Brasil

1:30 pm - 4:00 pm

Recent Advances in Transporters and Human PK - Session 1
Cristiano Guimaraes, Aché Laboratórios Farmacêuticos S. A. and Ayman El-Kattan, Pfizer

Tuesday 29 July

7:30 am - 8:30 am

Registration & Continental Breakfast

8:30 am - 9:00 am

Welcome & Opening Remarks

Welcome
Mike S. Lee
Milestone Development Services

Format, Objectives, Opening Remarks
Daniel Lebre
CEMSA Laboratories

9:00 am - 10:00 am

Plenary Lecture

Microspray and Microflow Liquid Chromatography: The Perfect Fit for Modern LC-MS Bioanalyis. (abstract)
Shane Needham
Alturas Analytics

10:00 am - 10:30 am

Break/Roundtables

10:30 am - 12:00 pm

Challenges and Opportunities Faced in BA/BE Studies
Chair: Gary Impey, AB Sciex

Future Trends of Bioequivalence: An Anvisa Perspective

Gustavo Santos, ANVISA

BE/BA in Brazil: Past, Present and Future Perspectives

Katia Pastre, MAGABI (Eurofarma)

Global Bioanalysis Consortium Update and Related Topics

Maria Francesca Riccio, CAEP

12:15 pm - 1:15 pm

Sponsored Lunch & Roundtable Event
Sponsored by AB Sciex

1:30 pm - 3:00 pm

Biomarker and Clinical Analysis
Chair: Dulce Casarini, Universidade Federal de São Paulo

Companion Diagnostics and Personalized Medicine in LatAm

Roberto Araújo, Reprogenetics Brazil

Proteomics for Revealing Biomarkers and Understanding Clinical Depression

Daniel Martins-de-Souza, University of Campinas

Monitoring of Biological Processes and Identification of Biomarkers in Renal Transplantation

Juliana Dinéia Perez, Universidade Federal de São Paulo

3:00 pm - 3:30 pm

Break/Roundtables

3:30 pm - 5:00 pm

A Perspective of Pharmaceutical Development in Brazil
Chairs: Rafael Barrientos, Eurofarma and Lauro Moretto, Sindusfarma

A Regulatory Perspective: RDC58/13-Degradation Products
Sâmia Rocha de Oliveira Melo, ANVISA

An Industry Perspective: Overview on the Pharmaceutical Development in Brazil
Gabriel Lima Barros Araujo, University of Sao Paulo

A Third Party Perspective: Challenges on the Analytical Development
Luiz Silva, US Pharmacopeia

Wednesday 30 July

7:30 am - 8:30 am

Registration & Continental Breakfast

8:30 am - 9:30 am

Plenary Lecture

Some Thoughts on Biomarker Translation (abstract)
Randall Nelson
Arizona State University

9:30 am - 10:00 am

Break/Roundtables

10:00 am - 11:30 am

Protein Quantitation
Chair, Nalini Sadagopan, Agilent Technologies

Protein Quantitation by Mass Spectrometry

Nalini Sadagopan, Agilent Technologies

Analytical Systems for Biology

Rick King, PharmaCadence Analytical Services

Biomarkers of Diabetes in Plasma of Non-Obese Diabetic Mice

Juliana Almada Colucci, Universidade Federal de São Paulo

11:45 am - 12:45 pm

Sponsored Lunch & Roundtable Event
Sponsored by Agilent Technologies

A View on Analytical Capabilities for Pharmaceutical Development

Rafael Barrientos, Eurofarma

Novel Chromatographic Solutions for Pharmaceutical Development

Nalini Sadagopan, Agilent Technologies

1:00 pm - 2:30 pm

Drug Discovery and DMPK
Chair: Marcos Eberlin, University of Campinas

Phenotypic Screening for Drug Discovery for Neglected Diseases and Its Advantages in Lead Optimization Studies

Lucio Freitas-Junior, National Laboratory of Biosciences (LNBio)

ABC of Handling New Chemical Entities with Active Hepatic Uptake as a Rate Determining Step: Industrial Perspective

Ayman El-Kattan, Pfizer

Use of LC-MS/MS in the Pre-Clinical and Clinical Development of Dapaconazole, a Novel Antifungal Agent

Gilberto De Nucci, Universidade de São Paulo

2:30 pm - 2:45 pm

Wrap Up & Adjourn
Daniel Lebre, CEMSA and Mike Lee, Milestone Development Services

CPSA Brasil 2014

Emerging Models for Drug Development and the Clinical Laboratory: Innovative Technologies and Future Applications

Final Program Agenda